We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.25 | 16.50 | 18.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 644k | -2.04M | -0.0208 | -8.29 | 16.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/12/2024 20:27 | I know a few smart dudes who know Morepen's financials very well you see. They had a look at SLimeShady performance from other outlets and just asking | putinaire | |
03/12/2024 20:26 | Finally, can i see what data the forecasts were based upon please Thanks | putinaire | |
03/12/2024 20:24 | Why is OPTI not forecasting the revenues directly, via a UK RNS? Off-shore forecasts attached seem a bit iffy | putinaire | |
03/12/2024 20:23 | Varun Suri, CEO of Dr Morepen commented: "We see the partnership between Dr. Morepen and OptiBiotix as an important one and have high regard for the success OptiBiotix enjoys globally because of the science and functionality of the ingredient and trust in their brand. ......... Ummmm, shall believe everything he says in future | putinaire | |
03/12/2024 20:22 | So, OPTI agree with that forecast? | putinaire | |
03/12/2024 20:21 | "Based on Morepen's current forecasts, this agreement could contribute in the region of £6-7 million revenue per annum to OptiBiotix in the next four to five years. ..... Let me guess Year 1-3, zero, then morepen gets suspended? | putinaire | |
03/12/2024 20:18 | Well at least we can see what revenues are coming in from KAG and marry it up to Morepen books anyway | putinaire | |
03/12/2024 20:15 | This is being supported by a £1.5million+ marketing investment........ Who is accounting for it? | putinaire | |
03/12/2024 20:14 | Were they excited by the performance of Slimbiome in H&B and thought it worthy of a 1.5M marketing investment? | putinaire | |
03/12/2024 12:25 | I found the secret formula in a Popeye cartoon actually….. ( share price X 2 + RNS - transparency + placing = 0 ) | kreature | |
03/12/2024 11:26 | Anyone know the formula to apply for crackpipe makers? Do u know I think me mate discovered it | putinaire | |
03/12/2024 11:22 | Tbf il ask somebody else to do it for me. I cant even translate what I typed. I got it from chatgbt | putinaire | |
03/12/2024 11:19 | At least we can then all ponder the future based on facts u see , and extrapolate from that, imaginary measures for postive ski slopes | putinaire | |
03/12/2024 11:16 | Might have a bit of fun here and on sbtx next week and apply an analysis that would be used on mega caps. A () return can be given . We will go through it all. Cash flows, breakeven, risk..the whole shabang I'm going to take a wild guess prior and say -57pps | putinaire | |
03/12/2024 10:04 | Definitely be no side affects. Guaranteed | putinaire | |
03/12/2024 10:03 | Or a croda/sbtx special. | putinaire | |
03/12/2024 10:02 | Tbf, I'd recommend a skin transplant. | putinaire |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions